The crosstalk between breast cancer and its microenvironment is one of the reasons for the tumour-associated stromal mediated mechanism of treatment resistance, for example in aromatase resistance may be caused by abnormal growth factor receptors expression [25]. This evidence concerns the gene CYP19A1 and breast carcinoma.